Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Tailoring the dosage to the patients tolerance and goals supports stable and sustainable health improvements
Late 2026 to Q1 2027: NDA submission to the FDA, assuming all trials are successful
BYETTA provides sustained A1C control and low incidence of hypoglycemia when used alone or in combination with metformin or a thiazolidinedione, with potential weight loss (BYETTA is not a weight-loss product)
This makes it particularly well suited to patients who value facial softness and volume, while still wanting measurable lifting, tightening and improvement in skin texture
Avoid injecting into: Skin that is bruised, tender, scarred, or affected by a rash Areas with visible lipohypertrophy or lipoatrophy (sunken skin) The waistband area or near bony prominences If you notice persistent lumps, skin changes, or unusual discomfort at injection sites, report these to your healthcare professional promptly
Reducing appetite: They can help reduce overall food intake, contributing to weight management
US$ 26.11
US$ 22.24
US$ 27.47
US$ 26.95
